Innovation
Entrepreneurship and innovation enable Weill Cornell Medicine to bring discoveries to patients faster.
Weill Cornell Medicine investigators enjoy robust programs dedicated to nurturing, protecting and commercializing their discoveries. By translating groundbreaking research into revolutionary care through commercial partnerships, lifechanging diagnostics, treatments and healthcare solutions can reach patients faster than ever before. Weill Cornell Medicine Enterprise Innovation fosters a culture of innovation and entrepreneurship to build the next generation of leaders in life sciences industries and new ventures.
News
Entrepreneurship Fuels Scientific Advancement for Early-Career Scientist
Dr. Cheuk Man Cherie Au, assistant professor of pharmacology research in medicine, shares her insights and experience navigating the realms of academia and entrepreneurship.
New Genetic Signatures Can Classify Breast Cancers and Guide Prognosis
Researchers at Weill Cornell Medicine have developed breast cancer cell-of-origin signatures that can better predict both overall and progression-free survival of patients.
Cornell Inventors Celebrated at Cross-Campus Event
The Center for Technology Licensing recognized Cornell University and Weill Cornell Medicine researchers’ milestones in the intellectual property and commercialization process.
2024 Business Plan Challenge Pitch Competition Supports Innovation for Health Care Challenges
Three faculty-led teams won cash prizes at the BioVenture eLab Business Plan Challenge pitch competition judged by venture capitalists.
Views on Innovation
Dr. Barbara Hempstead, Dean, Weill Cornell Graduate School of Medical Sciences
Our accomplished physicians and scientists have a legacy of catalyzing research discoveries into new modalities and therapies that help transform human health.
Dr. John P. Leonard, Senior Associate Dean of Innovation and Initiatives
Getting new innovations across the finish line requires collaboration, often with industry partners, to scale up findings for application in healthcare.
Dr. William Polvino, CEO of Bridge Medicines
Tri-Institutional Therapeutics Discovery Institute and Bridge Medicines put the skill of a pharmaceutical company on the campuses of three great institutions.
Dr. Francis Barany, Professor of Microbiology and Immunology
The professionals at Enterprise Innovation possess strong first-hand knowledge of what it takes to start a company.
Become Engaged